Lansopram Pakningsstørrelser ≤ 56 Stk.

Lansoprazole, the active ingredient in Lansopram Pakningsstørrelser ≤ 56 Stk., is a proton pump inhibitor presented as a tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, duodenal and gastric ulcers, and is used in H. pylori eradication regimens.

GNH USA supplies Lansopram Pakningsstørrelser ≤ 56 Stk. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to reduce gastric acid production in several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): relieves heartburn and esophageal irritation. - Duodenal ulcer: promotes healing by decreasing acid exposure. - Gastric ulcer: accelerates ulcer resolution. - Helicobacter pylori eradication (in combination therapy): enhances antibiotic effectiveness. - Prevention of NSAID‑induced gastric ulcers: protects the stomach lining during NSAID use.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Stevens‑Johnson syndrome: blistering skin and mucous membranes. - Liver enzyme elevation: signs of hepatic stress. - Pancreatitis: upper abdominal pain radiating to the back.

Before initiating therapy, consider the following precautions: - Renal function assessment: adjust use in severe impairment. - Hepatic monitoring: watch for elevated liver enzymes. - Concomitant drug review: avoid known major interactions. - Hypersensitivity check: discontinue if allergic reaction occurs. - Elderly patients: start with the lowest effective dose. - Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole may affect the pharmacokinetics of several medicines. Major Interactions (Avoid): - Clarithromycin: increased plasma levels of lansoprazole. - Ketoconazole: reduced absorption of ketoconazole. - Atazanavir: decreased atazanavir exposure. Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect. - Phenytoin: possible reduction in phenytoin levels. - Oral contraceptives: may diminish contraceptive efficacy.